Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response
- 787 Downloads
AMPK was shown to negatively regulate FcεRI activation, and FcεR-mediated Fyn activation can counteract the LKB1/AMPK axis in mast cells. However, the relationship between the major Src family kinase Lyn and AMPK remains poorly defined. Here, we investigate the molecular mechanism for AMPK inhibition by FcεRI-Lyn signaling in rat RBL-2H3 cells. We found that FcεRI activation could rapidly inhibit AMPK activation through increased AMPK phosphorylation at the inhibitory Ser485/491 residues without a change at the activating Th172 residue, and this was accompanied by a reduction of ACC phosphorylation. Using specific inhibitors and gene silencing, we found that such AMPK inhibition involved a signaling cascade through Lyn-Syk-Akt. When AMPK was activated by AICAR, A769662 and metformin, FcεRI-mediated Syk, ERK, JNK and p38 activation, and TNFα release were all inhibited. Consistently, AMPK inhibition by compound C increased FcεRI-mediated Lyn activation. Moreover, AMPK activation dominantly impaired IgE-induced recruitment of signal proteins to the FcεRI by blocking the formation of FcεRIβ-Lyn-Syk, FcεRIγ-Lyn-Syk, and AMPK-FcεRIβ complexes. In vitro kinase assay further revealed the ability of AMPKα2 to phosphorylate FcεRIβ in the complex. In vivo, AMPK activation by metformin could readily reduce vascular permeability and ear swelling in a mouse model of passive cutaneous anaphylaxis mediated by IgE. In summary, our findings demonstrate that IgE-mediated FcεRI activation results in AMPK inhibition through activation of Lyn-Syk-Akt pathway, and as such FcεRI receptor can efficiently propagate Lyn-mediated allergic signaling and response. These results provide important insights into the use of AMPK activators for the treatment of allergic diseases.
AMPK is inhibited by FcεRI via Lyn-Syk-Akt signaling in RBL-2H3 cells.
AMPK inhibition supports FcεRI-mediated Lyn signaling and allergic response.
Metformin has inhibitory effect on passive cutaneous anaphylaxis.
KeywordsAMPK FcεRI Syk Akt Basophils Anaphylaxis
AMP-activated protein kinase
Bone marrow-derived mast cells
2,4-Dinitrophenylated bovine serum albumin
Fcepsilon receptor I
Human serum albumin
Immunoreceptor tyrosine-based activation motif
Linker for activation of T cell
Liver kinase B1
Mitogen-activated protein kinase
Passive cutaneous anaphylaxis
Protein tyrosine kinase
Src family kinase
Small interfering RNA
Spleen tyrosine kinase
This work was supported by a grant from the Ministry of Science and Technology (MOST 103-2320-B-002-069 -MY3).
Conflict of interest
The authors declare that they have no competing interests.
- 13.Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A, Schlattner U, Wallimann T, Carling D, Hue L et al (2006) Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. J Biol Chem 281:5335–5340CrossRefPubMedGoogle Scholar
- 27.Liu WM, Huang P, Kar N, Burgett M, Muller-Greven G, Nowacki AS, Distelhorst CW, Lathia JD, Rich JN, Kappes JC, Gladson CL (2013) Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy. PLoS One 8:e70804Google Scholar
- 28.Calixto MC, Lintomen L, André DM, Leiria LO, Ferreira D, Lellis-Santos C, Anhê GF, Bordin S, Landgraf RG, Antunes E (2013) Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS One 8:e76786Google Scholar